Basis: Current FMP quote-based enterprise value / four-quarter operating income plus matched D&A. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/EBITDA ratio is N/A as of 2026-10-06T15:47:26.465Z.
Calculation as of: 2026-10-06T15:47:26.465Z.
Quote observation: 2026-10-06T15:45:09.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 55b8dbabd3995de6814355fb2a21bc992d842325745fe4a48a34f8d646fc1b47
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-05-06.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/EBITDA RATIO
N/A
EV/EBITDA RATIO AVG TTM
N/A
EV/EBITDA RATIO AVG 3Y
N/A
EV/EBITDA RATIO AVG 5Y
N/A
EV/EBITDA RATIO AVG 10Y
N/A
EV/EBITDA RATIO AVG 15Y
N/A
EV/EBITDA RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Mirum Pharmaceuticals, Inc.
Market Cap
$4.92B
EV/EBITDA Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$4.86B
EV/EBITDA Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$5.08B
EV/EBITDA Ratio
16.16x
TTM Avg
15.97x
3Y Avg
19.93x
5Y Avg
21.74x
Market Cap
$4.75B
EV/EBITDA Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$4.70B
EV/EBITDA Ratio
35.15x
TTM Avg
39.32x
3Y Avg
75.54x
5Y Avg
104.36x
Market Cap
$4.65B
EV/EBITDA Ratio
13.96x
TTM Avg
13.23x
3Y Avg
15.13x
5Y Avg
17.95x
Market Cap
$5.21B
EV/EBITDA Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | EV/EBITDA RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Mirum Pharmaceuticals, Inc. (MIRM) | $4.92B | N/A | N/A | N/A | N/A |
| Oruka Therapeutics, Inc. (ORKA)vs › | $4.88B | N/A | N/A | N/A | N/A |
| Dianthus Therapeutics, Inc. (DNTH)vs › | $4.86B | N/A | N/A | N/A | N/A |
| Merit Medical Systems, Inc. (MMSI)vs › | $5.08B | 16.16x | 15.97x | 19.93x | 21.74x |
| Definium Therapeutics, Inc. (DFTX)vs › | $4.75B | N/A | N/A | N/A | N/A |
| Erasca, Inc. (ERAS)vs › | $5.13B | N/A | N/A | N/A | N/A |
| LifeStance Health Group, Inc. (LFST)vs › | $4.70B | 35.15x | 39.32x | 75.54x | 104.36x |
| Option Care Health, Inc. (OPCH)vs › | $4.65B | 13.96x | 13.23x | 15.13x | 17.95x |
| Scholar Rock Holding Corporation (SRRK)vs › | $5.21B | N/A | N/A | N/A | N/A |
| BillionToOne, Inc. (BLLN)vs › | $4.62B | 75.89x | 416.98x | 416.98x | 416.98x |
EV/EBITDA = Enterprise Value / EBITDA (TTM)
Enterprise value to EBITDA is a capital-structure-neutral valuation multiple, useful for comparing companies with different debt levels and tax rates.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EV/EBITDA RATIO |
|---|---|
| 2026-05-06 | 2632.16x |
| 2026-05-05 | 2530.48x |
| 2026-05-04 | 2530.00x |
| 2026-05-01 | 2309.49x |
| 2026-04-30 | 2328.07x |
| 2026-04-29 | 2254.01x |
| 2026-04-28 | 2249.25x |
| 2026-04-27 | 2213.05x |
| 2026-04-24 | 2189.47x |
| 2026-04-23 | 2200.43x |
| 2026-04-22 | 2256.63x |
| 2026-04-21 | 2233.29x |
| 2026-04-20 | 2289.97x |
| 2026-04-17 | 2343.31x |
| 2026-04-16 | 2293.54x |
| 2026-04-15 | 2306.40x |
| 2026-04-14 | 2318.30x |
| 2026-04-13 | 2308.54x |
| 2026-04-10 | 2277.82x |
| 2026-04-09 | 2367.12x |
| 2026-04-08 | 2343.31x |
| 2026-04-07 | 2288.54x |
| 2026-04-06 | 2302.59x |
| 2026-04-02 | 2253.29x |
| 2026-04-01 | 2264.01x |
| 2026-03-31 | 2210.67x |
| 2026-03-30 | 2103.98x |
| 2026-03-27 | 2116.84x |
| 2026-03-26 | 2127.32x |
| 2026-03-25 | 2158.04x |
| 2026-03-24 | 2103.51x |
| 2026-03-23 | 2140.42x |
| 2026-03-20 | 2118.51x |
| 2026-03-19 | 2171.14x |
| 2026-03-18 | 2193.52x |
| 2026-03-17 | 2309.97x |
| 2026-03-16 | 2216.86x |
| 2026-03-13 | 2169.71x |
| 2026-03-12 | 2148.75x |
| 2026-03-11 | 2195.67x |
| 2026-03-10 | 2176.14x |
| 2026-03-09 | 2124.94x |
| 2026-03-06 | 2065.88x |
| 2026-03-05 | 2102.56x |
| 2026-03-04 | 2226.38x |
| 2026-03-03 | 2101.60x |
| 2026-03-02 | 2156.14x |
| 2026-02-27 | 2208.52x |
| 2026-02-26 | 2206.14x |
